Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapy of cutaneous lymphoma--current practice and future developments.

R Dummer1, W Kempf, M Hess Schmid

  • 1Department of Dermatology, University Hospital of Zurich, Switzerland. reinhard.drummer@usz.ch

Onkologie
|September 16, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Vivo Feasibility of Arterial Embolization with Permanent and Absorbable Suture: The FAIR-Embo Concept.

Cardiovascular and interventional radiology·2019
Same author

The contact sensitizer diphenylcyclopropenone has adjuvant properties in mice and potential application in epicutaneous immunotherapy.

Allergy·2012
Same author

The spectrum of mesenchymal skin neoplasms reflected by the new WHO classification.

Onkologie·2004
Same author

[Cutaneous lymphoma].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2004
Same author

A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients.

The British journal of dermatology·2004
Same author

Combination of bexarotene and psoralen-UVA therapy in a patient with Mycosis fungoides.

Dermatology (Basel, Switzerland)·2004

Cutaneous lymphomas are clonal lymphoproliferative disorders requiring tailored, often non-aggressive treatments. Early stages benefit from local therapies like UV or radiotherapy, while advanced stages may need systemic drugs or experimental options.

Area of Science:

  • Oncology
  • Dermatology
  • Hematology

Background:

  • Cutaneous lymphomas encompass diverse clonal lymphoproliferative disorders affecting the skin.
  • Accurate diagnosis is crucial for determining appropriate, typically non-aggressive, treatment strategies.

Purpose of the Study:

  • To outline current and experimental therapeutic modalities for cutaneous lymphomas.
  • To emphasize the importance of stage-specific treatment selection.

Main Methods:

  • Review of established and emerging treatment options for cutaneous lymphomas.
  • Categorization of therapies based on disease stage (early vs. advanced).

Main Results:

  • Early-stage cutaneous lymphomas are often managed with local treatments like ultraviolet (UV) or radiotherapy.

Related Experiment Videos

  • Advanced-stage disease may necessitate systemic therapies, including interferon-alpha or bexarotene.
  • Vaccination and gene therapy represent emerging experimental approaches.

    • Conclusions:

    • Treatment for cutaneous lymphomas must be individualized based on precise diagnosis and disease stage.
    • A spectrum of therapeutic options exists, ranging from local interventions to systemic and experimental treatments.